a patient with subacute sclerosing panencephalitis. New England Journal of Medicine 1969;281:585-589.

Pollard JD, Selby G. Relapsing neuropathy due to tetanus toxoid: report of a case. Journal of Neurological Science 1978;37:113-125.

Rantala H, Uhari M, Niemela M. Occurrence, clinical manifestations, and prognosis of Guillain-Barré syndrome. Archives of Disease in Childhood 1991;66:706-709.

Rivers TM, Schwenker FF. Encephalomyelitis accompanied by myelin destruction experimentally produced in monkeys. Journal of Experimental Medicine 1935;61:689-702.

Ropper AH. The Guillain-Barré syndrome. New England Journal of Medicine 1992;326:1130-1136.

Ropper AH, Wijdicks EF, Truax BT. Guillain-Barré syndrome. Philadelphia: F.A. Davis; 1991.

Roscelli JD, Bass JW, Pang L. Guillain-Barré syndrome and influenza vaccination in the US Army. 1980-1988. American Journal of Epidemiology 1991;133:952-955.

Safranek TJ, Lawrence DN, Kurland LT, Culver DH, Wiederholt WC, Hayner NS, et al. Reassessment of the association between Guillain-Barré syndrome and receipt of swine influenza vaccine in 1976-1977: results of a two-state study. Expert Neurology Group. American Journal of Epidemiology 1991;133:940-951.

Scheinberg L, Allensworth M. Sciatic neuropathy in infants related to antibiotic injections. Pediatrics 1957;19:261-265.

Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, Keenlyside RA, Ziegler DW, Retailliau HF, et al. Guillain-Barré syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977. American Journal of Epidemiology 1979;110:105-123.

Sibley WA, Bamford CR, Clark K. Clinical viral infections and multiple sclerosis. Lancet 1985;1:1313-1315.

Soffer D, Feldman S, Alter M. Epidemiology of Guillain-Barré syndrome. Neurology 1978;28:686-690.

Sunderland S. Nerves and Nerve Injuries. Baltimore: The Williams & Wilkins Company; 1968.

Tsairis P, Dyck PJ, Mulder DW. Natural history of brachial plexus neuropathy: report on 99 patients. Archives of Neurology 1972;27:109-117.

Uhari M, Rantala H, Niemela M. Cluster of childhood Guillain-Barré cases after an oral poliovaccine campaign (letter). Lancet 1989;2:440-441.

U.S. Department of Health and Human Services. U.S. Public Health Service, National Vaccine Injury Compensation Program; Revision of the Vaccine Injury Table; Proposed Rule. Federal Register, 42 CFR Part 100, August 14, 1992;57(158):36877-36885.

Van Bogaert L. Une leucoencephalite sclerosante subaigue. Journal de Neurologie de la Psychiatrie 1945;8:101-120.

van der Meché FG, Schmitz PI, Dutch Guillain-Barré Study Group. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. New England Journal of Medicine 1992;326:1123-1129.

Waksman BH, Adams RD. Allergic neuritis: an experimental disease of rabbits induced by the injection of peripheral nervous tissue and adjuvants. Journal of Experimental Medicine 1955;102:213-235.

Winer JB, Hughes RA, Anderson MJ, Jones DM, Kangro J, Watkins RP. A prospective study of acute idiopathic neuropathy, II. Antecedent events. Journal of Neurology, Neurosurgery and Psychiatry 1988;51:613-618.

Winner SJ, Evans G. Age-specific incidence of Guillain-Barré syndrome in Oxfordshire. Quarterly Journal of Medicine 1990;77(New Series): 1297-1304.

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement